相关实验视频

Updated: Jul 2, 2025

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

开发针对SARS-CoV-2的CAR-免疫细胞疗法:当前状态,挑战和前景

Yizhao Chen¹, Chong Liu¹, Yilong Fang¹

¹Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Institute of Clinical Pharmacology, Anhui Medical University, Hefei 230032, China.

Biochemical pharmacology

|February 19, 2024

概括

化学抗原受体 (CAR) 免疫细胞疗法显示出清除瘤和SARS-CoV-2等病毒的前景. 这种方法有可能通过向病毒和调节免疫反应来恢复免疫平衡并对抗COVID-19.

科学领域:

免疫学免疫学免疫学
病毒学病毒学
生物技术是生物技术.

背景情况:

化学抗原受体 (CAR) 免疫细胞疗法通过精确向瘤,改变了癌症治疗.
目前正在探索CAR免疫细胞在病毒清除和免疫系统平衡中的潜力.
由SARS-CoV-2引起的COVID-19大流行突显了免疫失调,包括过度活跃的巨细胞和受损的自然杀手细胞,导致严重的结果.

研究的目的:

审查目前针对SARS-CoV-2感染的CAR免疫细胞疗法的研究.
讨论CAR免疫细胞的潜力,作为一种针对COVID-19的新疗法策略.
评估这种创新的免疫疗法的可行性,挑战和未来前景.

主要方法:

对针对SARS-CoV-2的CAR免疫细胞进行的研究的文献综述.
对COVID-19患者免疫系统调节失调的分析.
讨论病毒清除和免疫调节中的CAR-免疫细胞机制.

主要成果:

CAR免疫细胞在准SARS-CoV-2和调节免疫反应方面表现出潜力.
在COVID-19中免疫失调有助于疾病严重程度和病毒清除受损.
CAR免疫细胞疗法提供了一种新的方法来应对SARS-CoV-2感染带来的挑战.

结论:

汽车免疫细胞疗法为对抗SARS-CoV-2及其相关免疫失调提供了一个有希望的途径.
需要进一步的研究来克服挑战,并实现CAR免疫细胞对抗COVID-19的全部治疗潜力.
这种疗法可以提供一种新的策略,以实现病毒清除和恢复感染个体的免疫恒温.

关键词:

化学抗原受体T细胞的T细胞化学抗原受体巨细胞化学抗原受体是自然杀手细胞的受体.新冠病毒疾病2019年免疫治疗是一种免疫疗法.严重急性呼吸系统综合征冠状病毒2

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Published on: February 2, 2024

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...